Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.69 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | RAB9A | P51151 | 2/20 | 0.64 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.60 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.57 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | LDHA | P00338 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30792366 | 0.91 | FFAR1 (0.81) | FFAR1NPC1RAB9AF2RL1LMNA | |
| SCHEMBL274471 | 0.91 | FFAR1 (0.81) | FFAR1NPC1RAB9AF2RL1LMNA | |
| SCHEMBL1566761 | 0.86 | FFAR1 (0.73) | FFAR1NPC1RAB9AF2RL1LMNA | |
| Anisole SCHEMBL31387002 | 0.86 | FFAR1 (0.74) | FFAR1NPC1RAB9AF2RL1SRD5A2 | |
| Anisole SCHEMBL30496784 | 0.83 | FFAR1 (0.70) | FFAR1NPC1RAB9AF2RL1SRD5A2 | |
| SCHEMBL7868896 | 0.82 | NPC1 (0.83) | FFAR1NPC1RAB9AF2RL1PDE4B | |
| SCHEMBL14531442 | 0.82 | FFAR1 (0.59) | FFAR1NPC1RAB9AF2RL1PDE4B | |
| SCHEMBL28647901 | 0.82 | NPC1 (0.69) | FFAR1NPC1RAB9AF2RL1L3MBTL1 | |
| SCHEMBL5250063 | 0.82 | FFAR1 (1.00) | FFAR1NPC1RAB9AF2RL1LMNA | |
| SCHEMBL5702383 | 0.82 | FFAR1 (0.68) | FFAR1NPC1RAB9AF2RL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080248584-A1 | Biopolymer ionization; liquid chromatography | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2008-10-09 | — | — | US | disclosed |
| EP-1700116-A1 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2006-09-13 | — | — | EP | disclosed |
| US-20060022129-A1 | Peptide mass spectrometry rich in daughter ions | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2006-02-02 | — | — | US | disclosed |
| EP-1600776-A2 | Peptide mass spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2005-11-30 | — | — | EP | disclosed |
| WO-2005057207-A1 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2005-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248584-A1 | Biopolymer ionization; liquid chromatography | F12, F13B, F13A1 | FFAR1 4779/4885NPC1 4179/4885RAB9A 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.